Metabolism.com
  • Home
  • About us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us
Select Page
Anti-obesity Medications 2023: The Controversy Continues

Anti-obesity Medications 2023: The Controversy Continues

by Gary Pepper M.D. | Jan 16, 2023 | NUTRITIONAL-HEALTH

 by Gary M. Pepper, M.D. and Sam Jeans, MSc The global anti-obesity drug market, in 2021was valued at over $2 billion. Within one year this figure had skyrocketed to $8 billion and is expected to climb to nearly $ 20 billion by 2027. This astounding growth is a...
Weight Loss Drugs: An Overview for 2022

Weight Loss Drugs: An Overview for 2022

by Gary Pepper M.D. | Aug 23, 2022 | NUTRITIONAL-HEALTH

By Gary M. Pepper, M.D. , Sam Jeans MSc To help clarify the effectiveness, side effects and cost of weight loss drugs now available,  Metabolism.com is providing this breakdown for consumers. According to the CDC, the prevalence of obesity in the USA is...

FDA to Weight Loss Drug Developers: “Drop Dead!!”

by Dr. G. Pepper | Feb 13, 2011 | diet, diet and weight loss, fitness, general health & nutrition, health, hormones, metabolism, nutrition, weight gain

In just the last few months the FDA shot down applications from three new weight loss drugs and removed one from the market that was previously approved. A month ago, based on analysis of these actions, I predicted it will take 10 years for a new weight loss drug to...

Categories

Polls

  • Polls Archive

After graduating from fellowship in Endocrinology
and Metabolism at Mt. Sinai School of Medicine in
New York, in 1981.

COMPANY

  • Home
  • About Us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us

RESOURCES

  • Blog
  • Terms & Condidtions
  • Privcay Policy
  • Disclaimer

CONTACT US

  • info@metabolism.com
  • P.O. Box 2743, Jupiter,
    Florida 33468

Copyright © 2023 Metabolism.com